Detalhe da pesquisa
1.
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.
Cancer Immunol Immunother
; 72(4): 827-840, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083313
2.
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02).
Oncologist
; 24(11): e1115-e1122, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31235483
3.
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.
Mol Cancer
; 22(1): 13, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670412
4.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Br J Cancer
; 117(12): 1777-1786, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123263
5.
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Br J Cancer
; 115(7): 789-96, 2016 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27599039
6.
[Histological factors predicting loco-regional lymph node metastasis in early invasive colorectal adenocarcinoma pT1]. / Estudio de factores histológicos predictivos de metástasis ganglionar locorregional en adenocarcinoma colorrectal mínimamente invasivo pT1.
Gastroenterol Hepatol
; 39(1): 1-8, 2016 Jan.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26049903
7.
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.
Oncologist
; 19(10): 1042-3, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25209376
8.
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.
Clin Cancer Res
; 30(4): 695-702, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051750
9.
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
J Natl Cancer Inst
; 115(12): 1497-1505, 2023 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405857
10.
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
Oncologist
; 17(7): 947-55, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22643538
11.
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
Oncologist
; 17(1): 15-25, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234633
12.
Clinically relevant study end points in rectal cancer.
Recent Results Cancer Res
; 196: 3-19, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129363
13.
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Br J Cancer
; 115(9): e16, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727233
14.
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Tumour Biol
; 32(2): 417-24, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21104178
15.
Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT.
J Clin Med
; 10(10)2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34069240
16.
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
Clin Cancer Res
; 27(10): 2890-2898, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727257
17.
Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials.
Cancers (Basel)
; 12(12)2020 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33291454
18.
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
JAMA Oncol
; 5(11): 1566-1573, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465088
19.
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
JCO Precis Oncol
; 3: 1-16, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100697
20.
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Neoplasia
; 20(7): 678-686, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29842993